Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Quantitative assays suggest that several reported agonists of the receptor TrkB do not indeed activate TrkB signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several proposed low molecular weight TrkB agonists have raised reproducibility and target specificity concerns, and central exposure remains difficult to optimize across scaffolds [131,132].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [132]
In the citing paper
“Many scaffolds suffer rapid clearance, metabolic instability, and uneven brain exposure [62,131,132].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [132]
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · cited 1×
“BDNF induced a robust signal in the PathHunter assay with an S/B ratio of 4 to 6 and a Z′-factor, a screening window coefficient that assesses assay quality (44), equal to 0.”
MethodTrk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 1×
“Homodimers of BDNF, NT3, or NT4 induce TrkB dimerization and kinase activation through a series of autophosphorylation events at Tyr(515), Tyr, and Tyr(816) (64).”
BackgroundStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 1×
“BDNF infusion into select brain areas of mice or rats shows antidepressant (7–9) and anxiolytic effects (10, 11) by inducing synaptic plasticity (12, 13).”
BackgroundTrkB signalling pathways in LTP and learning
Minichiello, L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2738 · Cited by 1,055 · cited 1×
“BDNF release and TrkB activation lead to enhanced neurogenesis of different neurochemical cell types, synaptogenesis, and synaptic plasticity (1, 2), all of which affect memory (3) and cognitive enhancements (Fig.”
BackgroundBDNF and synaptic plasticity, cognitive function, and dysfunction
Lu, B., Nagappan, G., & Lu, Y. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_9 · Cited by 1,043
The antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890
Castrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864
Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)
Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00169-4 · Cited by 841
The promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease
Yoshii, A., & Constantine‐Paton, M. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20765 · Cited by 744 · cited 1×
“BDNF release and TrkB activation lead to enhanced neurogenesis of different neurochemical cell types, synaptogenesis, and synaptic plasticity (1, 2), all of which affect memory (3) and cognitive enhancements (Fig.”
BackgroundBDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743 · cited 2×
“Because the use of BDNF as a biopharmaceutical has been difficult owing to its poor pharmacokinetic properties (19, 20), development of small-molecule TrkB agonists and modulators has become an important goal (25).”
BackgroundA selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686 · cited 2×
“Deoxygedunin and 7,8-DHF were identified by screening natural product libraries for compounds that protect against staurosporine-induced apoptosis in murine brain–derived cell line overexpressing TrkB (26).”
BackgroundTrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C.-H., Kernie, S. G., Bassel-Duby, R., & Parada, L. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.023 · Cited by 634
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537 · cited 1×
“Furthermore, one of the mechanistic models for the fastacting antidepressant effect of ketamine invokes activity-dependent release of BDNF as the required downstream event after ketamine administration (18).”
BackgroundHock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523 · cited 1×
“BDNF concentration was found to be reduced in parietal cortices and hippocampi in postmortem brains of Alzheimer’s disease patients (22), and another report revealed that amyloid-b peptide induces truncation of TrkB and reduction of TrkB signaling (23).”
BackgroundDiscovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice
Zhang, B., Salituro, G., Szalkowski, D., Li, Z., Zhang, Y., Royo, I., Vilella, D., Dı́ez, M. T., Pelaez, F., Ruby, C., et al. (1999) · Science · doi:10.1126/science.284.5416.974 · Cited by 456
Self-citationBergami, M., Rimondini, R., Santi, S., Blum, R., Götz, M., & Canossa, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803702105 · Cited by 415 · cited 1×
“Chronic administration of fluoxetine and other selective serotonin reuptake inhibitors increases the phosphorylation of TrkB in the hippocampus and prefrontal cortex (15), and deletion of TrkB in hippocampal neurons of newborn mice inhibits the effects of antidepressants (16) and increases anxiety-like behavior in the…”
BackgroundSmall molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents
Massa, S. M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J. N., Nehama, D., Rajadas, J., & Longo, F. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41356 · Cited by 406 · cited 12×
“7,8-DHF (500 nM) LM22A-4 (500 nM) Deoxygedunin (500 nM) Concentration, log (M) % R es po ns e 0 25 75 100 TrkB activation AKT activation ERK1/2 activation EC50 % E R K 1/2 phosphorylation30 60 90 120 0 20 40 60 80 100 % E R K 1/2 phosphorylation −20 0 20 40 60 80 100 120 A C E B D −12 −11 −10 −9 −8 −12 −11 −10 −9 −8 T…”
BackgroundMethodResultInfluentialAn overview of technical considerations for Western blotting applications to physiological research
Bass, J. J., Wilkinson, D. J., Rankin, D., Phillips, B. E., Szewczyk, N. J., Smith, K., & Atherton, P. J. (2017) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12702 · Cited by 404
A Defined Methodology for Reliable Quantification of Western Blot Data
Taylor, S. C., Berkelman, T., Yadav, G., & Hammond, M. (2013) · Molecular Biotechnology · doi:10.1007/s12033-013-9672-6 · Cited by 397
Hashimoto, K. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02113.x · Cited by 388 · cited 1×
“BDNF infusion into select brain areas of mice or rats shows antidepressant (7–9) and anxiolytic effects (10, 11) by inducing synaptic plasticity (12, 13).”
BackgroundQuantifying Western blots: Pitfalls of densitometry
Gassmann, M., Grenacher, B., Rohde, B., & Vogel, J. (2009) · ELECTROPHORESIS · doi:10.1002/elps.200800720 · Cited by 365 · cited 1×
“Moreover, densitometry is dependent on the analysis procedure, which may lead to biased results, especially with a low amount of phosphorylation of the protein of interest (50).”
BackgroundBekinschtein, P., Cammarota, M., & Medina, J. H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.024 · Cited by 349 · cited 1×
“BDNF release and TrkB activation lead to enhanced neurogenesis of different neurochemical cell types, synaptogenesis, and synaptic plasticity (1, 2), all of which affect memory (3) and cognitive enhancements (Fig.”
BackgroundKaplan, D. R., Matsumoto, K., Lucarelli, E., & Thielet, C. J. (1993) · Neuron · doi:10.1016/0896-6273(93)90187-v · Cited by 345
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
Longo, F. M., & Massa, S. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4024 · Cited by 298 · cited 1×
“Because the use of BDNF as a biopharmaceutical has been difficult owing to its poor pharmacokinetic properties (19, 20), development of small-molecule TrkB agonists and modulators has become an important goal (25).”
BackgroundZinc-Mediated Transactivation of TrkB Potentiates the Hippocampal Mossy Fiber-CA3 Pyramid Synapse
Huang, Y. Z., Pan, E., Xiong, Z.-Q., & McNamara, J. O. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.026 · Cited by 274 · cited 3×
“It is also known that TrkB can undergo transactivation through the activation of several G protein (guanine nucleotide–binding protein)–coupled receptors or receptor tyrosine kinases, for example, epidermal growth factor receptor and SRC (40, 42, 55, 56).”
BackgroundTrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
Gupta, V., You, Y., Gupta, V., Klistorner, A., & Graham, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 258 · cited 2×
“Because the use of BDNF as a biopharmaceutical has been difficult owing to its poor pharmacokinetic properties (19, 20), development of small-molecule TrkB agonists and modulators has become an important goal (25).”
BackgroundAn analysis of critical factors for quantitative immunoblotting
Janes, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005966 · Cited by 206
Chen, J., Chua, K., Chua, C. C., Yu, H., Pei, A., Chua, B. H. L., Hamdy, R. C., Xu, X., & Liu, C.-F. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.054 · Cited by 162
Schmid, D. A., Yang, T., Ogier, M., Adams, I., Mirakhur, Y., Wang, Q., Massa, S. M., Longo, F. M., & Katz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0865-11.2012 · Cited by 152 · cited 1×
“In vivo LM22A-4 improved motor and respiratory functions in mouse models of Rett syndrome and Huntington’s disease, respectively (35, 36).”
BackgroundNeurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150 · cited 2×
“BDNF infusion into select brain areas of mice or rats shows antidepressant (7–9) and anxiolytic effects (10, 11) by inducing synaptic plasticity (12, 13).”
BackgroundJang, S.-W., Liu, X., Chan, C.-B., Weinshenker, D., Hall, R. A., Xiao, G., & Ye, K. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.010 · Cited by 144 · cited 1×
“1) in living cells in vitro, including 7,8-dihydroxyflavone (7,8-DHF) (26), deoxygedunin (27), LM22A-4 (28), demethylasterriquinone B1 (DMAQ-B1) (29), amitriptyline (30), and deprenyl (31).”
BackgroundSimmons, D. A., Belichenko, N. P., Yang, T., Condon, C., Monbureau, M., Shamloo, M., Jing, D., Massa, S. M., & Longo, F. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1310-13.2013 · Cited by 144 · cited 1×
“In vivo LM22A-4 improved motor and respiratory functions in mouse models of Rett syndrome and Huntington’s disease, respectively (35, 36).”
BackgroundShi, T., Niepel, M., McDermott, J. E., Gao, Y., Nicora, C. D., Chrisler, W. B., Markillie, L. M., Petyuk, V. A., Smith, R. D., Rodland, K. D., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0891 · Cited by 132
Lowe, J. T., Lee, M. D., Akella, L. B., Davoine, E., Donckele, E. J., Durak, L., Duvall, J. R., Gerard, B., Holson, E. B., Joliton, A., et al. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo300974j · Cited by 130
Self-citationJiang, M., Peng, Q., Liu, X., Jin, J., Hou, Z., Zhang, J., Mori, S., Ross, C. A., Ye, K., & Duan, W. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt098 · Cited by 129 · cited 1×
“For example, systemic administration of 7,8-DHF to mice has been shown to have antidepressant effects (52), prevent memory loss in an Alzheimer’s disease model (53), and improve motor function in Huntington’s disease models (54).”
BackgroundRantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124
A solution for stripping antibodies from polyvinylidene fluoride immunoblots for multiple reprobing
Yeung, Y.-G., & Stanley, E. R. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.03.017 · Cited by 115 · cited 1×
“To quantify different proteins in the same plate, antibodies were stripped using stripping buffer (62) [6 M guanidine·HCl, 0.”
MethodLiu, X., Obianyo, O., Chan, C. B., Huang, J., Xue, S., Yang, J. J., Zeng, F., Goodman, M., & Ye, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562561 · Cited by 113 · cited 4×
“A report by the authorswho introduced 7,8-DHFas aTrkB agonist has suggested that its activity in primary cortical neuron cultures is dependent on the number of days in vitro (DIV) of the cultures and reported significant activation of the receptor beyond DIV 15 (33).”
BackgroundResultInfluentialSynaptic regulation of affective behaviors; role of BDNF
Ninan, I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.011 · Cited by 111
Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain
Jerónimo-Santos, A., Vaz, S. H., Parreira, S., Rapaz-Lérias, S., Caetano, A. P., Buée-Scherrer, V., Castrén, E., Valente, C. A., Blum, D., Sebastião, A. M., et al. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu105 · Cited by 107
Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Nakaso, K., Nakamura, C., Sato, H., Imamura, K., Takeshima, T., & Nakashima, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.095 · Cited by 101 · cited 2×
“Deprenyl has also been reported to induce TrkB phosphorylation in vitro (31).”
BackgroundZuccato, C., & Cattaneo, E. F. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_14 · Cited by 97
A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease
Todd, D., Gowers, I., Dowler, S. J., Wall, M. D., McAllister, G., Fischer, D. F., Dijkstra, S., Fratantoni, S. A., van de Bospoort, R., Veenman-Koepke, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087923 · Cited by 93 · cited 1×
“Although the difficulty of reproducing the reported in vitro results has been discussed at conferences for years, it is only recently that an independent research group has reported studies that failed to confirm some of the reported small-molecule compounds as TrkB agonists (7,8-DHF, LM22A-4, amitriptyline, andNacety…”
ResultEGF transactivation of Trk receptors regulates the migration of newborn cortical neurons
Puehringer, D., Orel, N., Lüningschrör, P., Subramanian, N., Herrmann, T., Chao, M. V., & Sendtner, M. (2013) · Nature Neuroscience · doi:10.1038/nn.3333 · Cited by 91 · cited 2×
“It is also known that TrkB can undergo transactivation through the activation of several G protein (guanine nucleotide–binding protein)–coupled receptors or receptor tyrosine kinases, for example, epidermal growth factor receptor and SRC (40, 42, 55, 56).”
Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves
English, A. W., Liu, K., Nicolini, J. M., Mulligan, A. M., & Ye, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303646110 · Cited by 91 · cited 1×
“Deoxygedunin was shown to promote axonal regeneration (34).”
BackgroundHan, X., Zhu, S., Wang, B., Chen, L., Li, R., Yao, W., & Qu, Z. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.018 · Cited by 86 · cited 1×
“Several studies have reported TrkB-independent neuroprotective effects of 7,8-DHF in in vitro cell models and attributed these to its antioxidant properties (57, 58).”
BackgroundTrkB inhibition as a therapeutic target for CNS-related disorders
Boulle, F., Kenis, G., Cazorla, M., Hamon, M., Steinbusch, H. W. M., Lanfumey, L., & van den Hove, D. L. A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.002 · Cited by 80
Liu, X., Qi, Q., Xiao, G., Li, J., Luo, H. R., & Ye, K. (2013) · Pharmacology · doi:10.1159/000346920 · Cited by 76 · cited 2×
“7,8-DHF is likely converted in the body into variousmetabolites that could induce the observed effects in vivo (52).”
BackgroundWestern blotting revisited: Critical perusal of underappreciated technical issues
Gorr, T. A., & Vogel, J. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400118 · Cited by 75
Zeng, Y., Liu, Y., Wu, M., Liu, J., & Hu, Q. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120886 · Cited by 70 · cited 1×
“For example, systemic administration of 7,8-DHF to mice has been shown to have antidepressant effects (52), prevent memory loss in an Alzheimer’s disease model (53), and improve motor function in Huntington’s disease models (54).”
BackgroundMutual Regulation of Src Family Kinases and the Neurotrophin Receptor TrkB
Huang, Y. Z., & McNamara, J. O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091041 · Cited by 68
Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays
Sadick, M. D., Intintoli, A., Quarmby, V. E., McCoy, A., Canova‐Davis, E., & Ling, V. W. T. (1999) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00144-7 · Cited by 62 · cited 1×
“Sandwich ELISA The amount of TrkB phosphorylation was quantified using the previously described kinase receptor activation–ELISA (61) with slight modification.”
MethodThe non‐peptidyl fungal metabolite L‐783,281 activates TRK neurotrophin receptors
Wilkie, N., Wingrove, P. B., Bilsland, J. G., Young, L., Harper, S. J., Hefti, F., Ellis, S., & Pollack, S. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00504.x · Cited by 49 · cited 14×
“However, no DMAQ-B1–induced TrkB phosphorylation was detected in cortical neuron cultures.”
BackgroundInfluentialSadick, M. D., Galloway, A., Shelton, D. L., Hale, V. G., Weck, S., Anicetti, V., & Wong, W. L. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3614 · Cited by 26 · cited 3×
“Although we detected no DMAQ-B1– induced TrkB phosphorylation in cortical neuron culture, we detected Concentration, log(M) % T rk B p ho sp ho ry la tio n −12 −11 −10 −9 −8 0 20 40 60 80 100 120 NGF BDNF NT4 NT3 * ******** **** **** **** ******** **** **** * K252a concentration log (M) % T rk B p ho sp ho ry la tio n…”
ResultInfluentialTransactivation of Trk receptors in spinal motor neurons.
Domeniconi, M., & Chao, M. V. (2010) · PubMed · doi:10.14670/hh-25.1207 · Cited by 20 · cited 2×
“It is also known that TrkB can undergo transactivation through the activation of several G protein (guanine nucleotide–binding protein)–coupled receptors or receptor tyrosine kinases, for example, epidermal growth factor receptor and SRC (40, 42, 55, 56).”
BackgroundUtilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells
Antila, H., Autio, H., Turunen, L., Harju, K., Tammela, P., Wennerberg, K., Yli‐Kauhaluoma, J. T., Huttunen, H. J., Ċastrén, E., & Rantamäki, T. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.11.001 · Cited by 20
Cellular Assays for High-Throughput Screening for Modulators of Trk Receptor Tyrosine Kinases
Wang, J., Hancock, M. K., Dudek, J. M., & Bi, K. (2008) · Current Chemical Genomics · doi:10.2174/1875397300801010027 · Cited by 17 · cited 1×
“TrkB phosphorylation results in PLCg activation, leading to an increase in Ca concentration and subsequent NFAT activation (65), which controls production of b-lactamase in these cells.”
BackgroundPowell, J. W. (1966) · Journal of the Chemical Society C Organic · doi:10.1039/j39660001794 · Cited by 14 · cited 1×
“09 (not integrated) [consistent with literature data (63)]; mass spectrometry (atmospheric pressure chemical ionization) value calculated for C28H34O6 is as follows: [M], 466.”
BackgroundA synthesis of methyl 2α-acetoxy-3-deoxo-3α-hydroxyangolensate
Kehrli, A. R. H., & TAYLOR, D. A. H. (1990) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19900002067 · Cited by 8
Bioinformatics Approach to BDNF and BDNF-Related Disorders
Dias, Á. M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596586 · Cited by 3 · cited 1×
“Owing to its role in this multitude of brain processes, studies focusing on the BDNF-TrkB signaling pathway are highly represented in the scientific and medical literature, with an exponential increase in the number of publications since 2000 (1700 papers in 2016, through PubMed search) (24).”
Background(1992) · PubMed
Cited by
BDNF signaling in context: From synaptic regulation to psychiatric disorders
Wang, C. S., Kavalali, E. T., & Monteggia, L. M. (2022) · Cell · doi:10.1016/j.cell.2021.12.003 · Cited by 607
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 193
“However, subsequent studies have raised doubts about these purported small-molecule modulators and whether they bind or activate TrkB 114,115 .”
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
BDNF signaling during the lifetime of dendritic spines
Zagrebelsky, M., Tacke, C., & Korte, M. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03226-5 · Cited by 147
Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy
Lin, T. W., Harward, S. C., Huang, Y. Z., & McNamara, J. O. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107734 · Cited by 117
Metadata
- Authors
- Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., & Sames, D.
- Affiliations
- Columbia University (US)
- Broad Institute (US)
- Department of Chemistry, Columbia University, New York, NY 10027, USA.
- Corresponding author
- Boltaev, Umed
- Meyer, Yves
- ORCID
- Venue
- Science Signaling
- Published
- 2017-08-22
- Volume
- 10
- Issue
- 493
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W2745540351
- Cited by
- 94
- References
- 66
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 15 · 2023: 17 · 2022: 7 · 2021: 11 · 2020: 8 · 2019: 11 · 2018: 8 · 2017: 2
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Funders
- G Harold and Leila Y. Mathers Foundation (award309491)
- Stanley Medical Research Institute, Broad Institute of MIT, and Harvard University (award309492)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- TrkB receptor, brain-derived neurotrophic factor, receptor activation, downstream signaling, gene expression, Alzheimer's disease, major depressive disorder, neurotrophic factors, drug target validation
- MeSH terms
- Animals, Cells, Cultured, Embryo, Mammalian, Enzyme-Linked Immunosorbent Assay, Humans, Membrane Glycoproteins, Neuroblastoma, Neurons, Phosphorylation, Signal Transduction, Brain-Derived Neurotrophic Factor, Receptor, trkB, Flavanones, Rats, Small Molecule Libraries, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.